With obesity trending in the wrong direction worldwide, obesity has more than doubled since 1990 GLP-1 meds can offer hope
The 2023-2024 FDA compounding restrictions do not currently list Ipamorelin or CJC-1295 (without DAC) as prohibited, though formulary status changes with regulatory updates
3
In summary, Se deficiency appears to be a risk factor for HT and the current evidence does not justify the use of Se supplementation as part of the treatment of HT, despite its ability to improve immune function
Anti-inflammatory Properties: When used together, BPC-157 and VIP peptides can synergistically combat inflammation
It restores a more youthful GH pulse pattern without replacing growth hormone directly, it has a cleaner side effect profile than older secretagogues, and the effects on sleep, recovery, body composition, and skin compound over 8 to 12 weeks in a predictable way